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Introduction  
Patients undergoing major cancer interventions such as major surgical resection, chemotherapy, 
radiotherapy, and immunotherapy are prone to the adverse effects of their cancer, as well as to the 
side effects of the treatments designed to cure them. For surgery, despite advancing innovations 
and the use of more minimal resection techniques, morbidity and mortality rates remain high (1,2), 
particularly amongst the older and most frail patients, who are more likely to adopt sedentary 
lifestyles (3,4). 
 
Prehabilitation (commonly known as “Prehab”) and supported recovery are increasingly recognised 
as important by people affected by cancer and healthcare providers internationally (5,6). Following a 
cancer diagnosis, the prehab process aims to optimise a person’s physical, nutritional, and 
psychological health in the time period before their cancer treatment begins and throughout 
treatment for non-surgical interventions (7). The core components of a multi-faceted prehab 
programme include cardiovascular and skeletal muscle fitness training, nutritional management, 
wellbeing with psychological support, and medical optimisation. This optimisation process supports 
the patient in preparing for the physiological challenges of their cancer treatments, whilst aiming to 
shorten recovery time, reduce peri-operative complications and improve compliance with non-
surgical treatments (8). 
 
The most effective prehab programmes provide a holistic approach to promote patient 
empowerment, adherence and improved experience; which includes a graded, evidence-based 
exercise prescription to give the best opportunity to improve fitness in the constrained time-period 
before cancer treatment (9). High-intensity interval training (HIIT) exercise provides an effective, 
time efficient approach to increasing fitness (needs ref), but any exercise could be viewed as 
potentially beneficial for patients (10). The rehabilitation side of the programme supports patients’ 
recovery from their cancer interventions and where necessary can be used to prepare them for 
other treatments (11). Rehabilitation should aim also to support the transition to lifelong exercise 
and so help in the prevention of future cardiovascular and cancer events (10). 
 
Most supporting evidence for prehab has come from surgical patients undergoing colorectal, lung 
and oesphago-gastric resections (12-17). There is currently less evidence supporting the use 
of prehab programmes in hepato-pancreato-biliary surgery but prehab studies in patients 
undergoing liver resection have shown improvement in pre-operative physical fitness especially in 
the least fit groups (18). Multi-modal prehab may prove to be particularly important in the surgical 
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treatment of pancreatic cancer, a diagnosis often associated with cachexia and malnutrition. Recent 
evidence from ongoing initiatives in Manchester (UK) recommends nutritional assessment and 
supplementation before and after major pancreas resection (personal communication).  
 
Prehabilitation is likely to be most useful in older cancer patient cohorts, who are more likely to have 
complex co-morbidities as well as sensory, balance or cognitive impairment with reduced functional 
abilities (19). Lawrence et al evaluated functional recovery following major abdominal surgery in 
older patients (mean age 69).  In the absence of a prehab or rehab programme, the results showed 
that eight weeks post-operation only 30% of patients had recovered to preoperative levels and at six 
months, only 50% had achieved baseline functional ability (20). 
 
This is supported by more recent evidence from the GOSAFE international evaluation and follow-up 
of older patients (mean age 78) undergoing major oncological surgery which reports on-going 
decreased functional capacity in 1/3 of colorectal patients at 3 months [21]. The objective of GOSAFE 
investigators (22) to provide meaningful data to assist clinicians in tailoring care of elderly patients 
to avoid under or overtreatment appears very pertinent and supports reports from others 
suggesting that older patients identify good functional recovery as a priority rather than duration of 
survival and (7,23) highlights quality of life as an important metric for prehabilitation. The 
development of a prehabilitation programme designed to derive optimal engagement and benefit 
for older people supports the recent focus from UK national health policy for healthcare innovations 
to support people to ‘age well’ (24), with greater consideration given to people experiencing mild, 
moderate and severe frailty (25). 
 
Rather than relying on chronological age, functional age appears a better predictor of outcomes (26) 
and this can be measured in a number of ways to allow detection of significant physiological and 
psychomotor defects.  Formal evaluation of older patients’ functional capacity would support fitter 
older patients to undergo more radical treatments, while protecting those who do not possess the 
required physiological reserve. It may also help to evaluate the outcomes of prehabilitation more 
effectively and ensure safe delivery of prehab programmes for such patient groups. 
 
The individualised prehab requirements of cancer patients based upon their functional, rather than 
chronological, age can be considered using the universal-targeted-specialised model endorsed by 
Macmillan-RCOA (7), (See figure 1). As patient needs increase, the level of support increases 
providing a ‘specialised’ healthcare-exercise service provision at the top of the triangle. 
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Case for change in cancer care Greater Manchester, UK 
 
Although there is growing evidence for the effectiveness of prehab, it has not yet been accepted into 
core clinical practice by the National Health System. Robust multi-centre trials are underway in the 
UK (27,28) and internationally (29) with the aim to evaluate prehabilitation care on a much larger 
scale than was previously conducted to derive the underpinning evidence of effectiveness and 
efficacy as well as patient acceptance of the interventions. 
 
People in Greater Manchester (GM) diagnosed with cancer tend to be less active and have poor 
health compared to other UK areas (30). Many have complex unmet health and social care needs 
throughout their treatment, which can remain for up to six months or more after treatments. Cancer 
outcomes was one of the composite health metrics that drove the creation of the Greater 
Manchester Health and Social Care Partnership (GMHSCP) Integrated Care System. In 2015, NHS 
organisations and councils agreed the GM devolution deal entrusting GM to ‘take charge’ of its own 
health and social care budget bringing together the social care and healthcare of its 2.8 million 
population. [31] 
 
This restructuring of the Greater Manchester (GM) healthcare system has supported innovative 
transformation projects for patients affected by cancer in GM including: the rapid screening 
programme for lung cancer, Enhanced Recovery After Surgery Plus (ERAS+) programme for major 
surgery, the CURE project to support smoking cessation, and prehab for those with cancer through 
the ‘Prehab4Cancer’ and recovery programme (32).  
 
Working with partners in Greater Manchester to improve surgical care 
The ERAS+ project  
Prehab for cancer patients undergoing surgery in GM has evolved from the surgical pathway 
innovation Enhanced Recovery After Surgery+ (ERAS+) (33), a pre and post-surgery care pathway 
designed and developed in GM and aimed to reduce pulmonary complications the most common 
significant complication after major surgery (34). The original implementation of ERAS+ at 
Manchester Royal Infirmary, demonstrated a 50% reduction in respiratory complications in patients 
undergoing major surgery and reduced hospital length of stay by 3 days (33).  
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ERAS+ is built on a traditional enhanced recovery after surgery stepped recovery approach and 
incorporates the ICOUGH respiratory bundle (35). As a direct innovation it integrates prehab into the 
ERAS pathway, with the aim of improving patient’s fitness before surgery with cardiovascular activity 
and muscle strengthening recommendations, alongside nutritional support, lifestyle advice and 
medical optimisation. This embedding of prehabilitation into ERAS is now being recognised as an 
essential step in major surgical care [8,36]. 
 
Patient and family education about the ERAS+ pathway are facilitated through the ‘Surgery School’ 
format. Patients are invited with family members, carers and friends to attend the multi-disciplinary 
education session prior to their surgery. At this 90 minute weekly-facilitated session, healthcare 
professionals (medical, nursing and Allied Healthcare Professionals) involved in the surgery care 
pathway ‘walk’ the patient and their accompanying friends/family members through the ERAS+ 
innovation with an emphasis on ‘training for their surgery’. Using behavioural change methodology, 
‘Surgery School’ is designed to empower patients and families, viewing major surgery preparation as 
a teachable moment (37,38). Pre-operative cardiovascular exercise, muscle strengthening, smoking 
cessation, medical optimisation, post-operative pain management are all explained alongside the 
ICOUGH aims of early mobilisation, good oral healthcare, use of incentive spirometers and early 
fluids and nutrition.  Patients and family members are encouraged to ask MDT members facilitating 
‘surgery school’ any questions they may have, and they are also invited to visit the High Dependency 
Unit and ward areas where they will be looked after following surgery. This helps to establish 
realistic expectations, reassurance and ‘normalisation’ to reduce any potential experience of anxiety 
a patient may be having in anticipation of their surgery. It was also found to strengthen the 
partnership between healthcare provider, patients, and their networks of support (unpublished 
data). 
 
Following its success at Manchester Royal Infirmary Hospital, the ERAS+ platform was adopted by 
the GMHSCP system for implementation at a further six NHS hospital  trust sites within the GM 
region as the GM ERAS+ programme, supported and funded by a Health Foundation Scaling up 
Improvement grant (2018-2020) (39).  
 
As part of the initial rolling out of the GM ERAS+ programme and the ambition to facilitate patients 
getting fitter prior to surgery (prehabilitation), hospital sites began to formulate links with their local 
GM borough leisure organisation health-focused partners to help consider and develop the delivery 
of community-based physical activity intervention prehabilitation for surgical patients in their 
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locality utilising existing exercise referral schemes.  These links were formed in parallel with the 
development of the CAN-Move exercise rehabilitation programme [40], a commissioned exercise 
referral scheme available for Salford residents recovering from cancer treatments including surgery 
and oncological interventions. The specialist exercise instructor leading this programme would 
become the Prehab4Cancer exercise lead.  
 
During a similar timeframe the GM Active board was conceived, bringing together 12 separate 
leisure and community organisations from across GM, working collaboratively to increase the levels 
of exercise and physical activity of the GM population. The formation of GM Active enabled 
relationships formed with individual leisure providers to be expanded to include health-focused 
representatives from all the GM leisure organisations, a progression which became a ‘lever’ for the 
concept of system-wide prehabilitation delivery at scale.  
 
Patients accessing the ERAS+ programme were signposted to local physical activity resources 
through their ERAS+ teams, during ‘pre-op’ appointments and ‘surgery school’ and were encouraged 
to attend on a voluntary basis. The community-based exercise referral schemes could be accessed by 
both oncological and non-oncological major surgical patients either free of charge, or with minimal 
costs, through locally agreed introductory rates. A combination of cardiovascular and resistance-
based training was provided to patients, using the existing referral fitness instructors in borough 
sites who were already delivering pulmonary rehabilitation, falls rehabilitation, pain management, 
cardiac rehabilitation and in some cases cancer rehabilitation sessions.  
 
Patients entering these preliminary programmes increased their exercise capacity in the pre-
operative period (unpublished data). There were, however, a number of barriers identified to wider 
scale adoption including organisation of gym referral and patient appointments; ownership of 
referral from secondary healthcare; differences in the exercise aspects on offer, variation in cost, 
which despite being mainly low it remained as a barrier to some patients undertaking the sessions.  
Importantly, there had not been a large-scale investment in secondary and primary care 
understanding of the gym prehab sessions and, as such, patients received inconsistent 
recommendation to engage from key clinicians within their surgical pathways, if any 
recommendation was made at all.  Prehab4Cancer focus groups comprised of People Affected By 
Cancer (PABC) confirmed this important barrier to engagement. It is therefore essential that 
surgeons, oncologists, Cancer Nurse Specialists (CNSs) and other key healthcare professionals 
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advocate engagement in prehab using consistent communication (similar language, explanation of 
the service, written information and positive affirmation). 
 
Prehab4Cancer design  
The evolving relationship of the GM secondary healthcare providers with the GM Active leisure 
organisation enabled learning to be adopted from the preliminary implementation of prehab in 
individual boroughs, fostered through the GM ERAS+ programme delivery. This in turn became a 
catalyst for key representatives from the GM Active board and the ERAS+ programme team to 
consider the development of a GM system-wide prehab service model for Greater Manchester ‘The 
Prehab4Cancer and Recovery programme’ with GM Cancer oversight and supported financially 
through transformation funding.  
 
The Prehab4Cancer (P4C) programme, with system-wide stakeholders now in place, was co-designed 
with PABC as patient involvement representatives, alongside cancer surgical pathway healthcare 
experts and exercise professionals from GM Active. The programme was initiated with an ambition 
to facilitate two thousand patients to undertake community-based prehabilitation and recovery, 
close to their residential address, in the eighty-six GM Active leisure facilities across the GM 
conurbation. Patients would be supported before (prehab) and after (rehabilitation) cancer 
treatments (including surgery, chemotherapy and radiotherapy), and where applicable during 
treatment, to have increased physical, nutritional and wellbeing support.  
 
The initial patient cohorts chosen, based upon the current strongest evidence base and reflective of 
the relationships already in places with GM ERAS+ teams, were colorectal, lung and oesophago-
gastric cancer surgery pathways (12-17). It was agreed that all patients resident in GM within these 
tumour groups and with an offer of curative surgery could additionally be offered ‘Prehab4Cancer’ 
as an integral component of their treatment pathway. Additional eligibility criteria included age >18 
and being able to safely participate in the exercise programme (41). 
 
Cancer clinical pathway specific subgroups for each surgical cohort worked closely with PABC and 
members of MDTs from around GM to design the specific surgical P4C pathway for their patients, 
supported by clinical (medical/therapies/psychological), academic and exercise expertise. Meetings 
took place on a monthly basis chaired by a clinical lead (surgeon or physician) and supported by the 
‘Prehab4Cancer’ programme and clinical leads. These subgroups informed the co-design and 
effective implementation of the referral process, patient uptake and adherence to the programme, 
8 
 
clinical considerations for programme delivery specific to tumour group cohorts and consistent 
communication for patients and family members. The output and ownership from these subgroups 
appear critical to the success of the programme delivery and would be a recommended component 
for the development of other prehab programmes being considered.  
 
The project team managing the delivery of P4C consists of a secondary healthcare clinical lead 
(anaesthetic and critical care consultant, with specialist experience in peri-operative medicine), 
primary care lead (Macmillan GP), GM Cancer programme lead (specialist occupational therapist 
with a background in complex rehabilitation and community NHS service leadership) and GM Active 
programme manager (former CAN-Move manager). The combination of members of this inter-
disciplinary team provided oversight of a patient’s journey from referral through treatment and into 
recovery, and a comprehensive understanding of the clinical and holistic needs of cancer patients.  
 
The governance structure (Figure2) which supports the project team and ultimately delivery of P4C 
includes an overarching steering group reporting into the GMHSCP via the GM Cancer Board, cancer 
clinical pathway specific subgroups, intervention-specific expert groups and an AHP Advisory board 
(including dietitians, occupational therapists, physiotherapists, speech and language therapists and 
PABC).  
 
Attention was particularly given to older patients considered to be high risk or identified to be pre-
frail/frail, agreeing assessments and interventions which could be graded to such patient cohorts for 
maximal engagement and safe delivery of the programme. As a result, relatively few patients are 
excluded from the programme with patients in their 70s, 80s and 90s effectively participating in P4C. 
This was further supported by education events to wider healthcare professional stakeholders 
involved in referral to the P4C service and who would be in contact with programme participants. 
 
P4C intervention 
The exercise interventions, pathways and outcome metrics (see table 1) for P4C were developed by 
the authors in partnership with PABC, the expert exercise and pathway subgroups and were aimed 
to improve patient cardiovascular fitness, muscle strengthening and incorporate nutritional and 
wellbeing support to complement existing provision within GM cancer patient pathways. 
 
The programme recognises many of the secondary symptoms that cancer patients experience 
related to their diagnosis and subsequent treatment including fatigue, low mood and feelings of 
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anxiety (42). It builds on widely understood principles surrounding exercise positively contributing to 
the reduction of such secondary symptoms, particularly related to mental health (43-45), with the 
overall aim of providing a holistic pathway to improve patient quality of life, during and after 
treatment. This in turn supports people with cancer to recover faster from their treatment with 
motivation for resumed independence and the ability to perform their pre-morbid occupations 
including returning to work, self-care and other important and personally meaningful activities of 
daily life.  
Participants’ wellbeing modality was constructed using the NICE 2004 stepped care model (46) 
approach to psychological support, highlighted in the Macmillan Prehabilitation Evidence and Insight 
report from 2017 (47), and accepted as an effective framework to deliver mental wellbeing 
assessment and intervention. 
In addition, by using well-equipped community-based leisure resources, as opposed to hospital 
gymnasiums, there was also the intention that this would support a secondary programme aim to 
induce long-term lifestyle behavioural change, supporting patients’ adoption of on-going exercise 
following discharge from the programme. 
 
Through existing partnerships with GM Active, the non-profit organisation UKactive, who represent 
the fitness and leisure sector partnered with the Prehab4Cancer team. Their research institute’s 
principal investigator provided input to the prehab-intervention design and training of GM Active 
staff, in addition to the reporting and evaluation of the exercise components. This included careful 
consideration of the timeframe available for the prehabilitation component (typically 3-4 weeks) and 
the minimal effective exercise dose that could be provided.  
 
Exercise dose was considered for both cardiovascular and resistance exercise based upon 
manipulation of the intensity of effort required (‘how potent?’), the volume/duration for which it 
was performed (‘how much?’), and also frequency of sessions across each week (‘how often?’). 
Within this, a standardised intervention was developed that enabled individualisation to scale to 
patient’s fitness levels (due to prescription based upon effort i.e. exercise demands relative to 
patient’s current capacity) and enabled flexibility in delivery across the various leisure facilities 
involved.  
 
An overview of the exercise prescriptions is shown in Table 2. Briefly, both followed progression in 
terms of the potency of dose prescribed based upon intensity of effort, a concomitant adaptation of 
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volume/duration in line with this, and fixed frequency of 3x/week sessions. The resistance training 
component provided a progressive intensity of effort with minimal effective dose as previously 
delivered for older adults (48-49). The cardiovascular training was adapted from the RE-HIIT 
(reduced exertion high intensity interval training) protocol providing a tolerable approach to HIIT 
(50). Exercise selection was deliberately flexible within this prescription to accommodate the varying 
equipment between sites of delivery, and patient preferences, functional limitations, and injuries. 
Resistance training included a minimum of 3 exercises performed to target the main large muscle 
groups of the body (upper body multi-joint push e.g. chest press/overhead press/seated dip; upper 
body multi-joint pull e.g. pulldown/seated row; and a lower body multi-joint exercise e.g. leg 
press/deadlift) with additional single-joint exercise included as supplementary where specific 
functional deficits existed. Similarly, cardiovascular training was performed using an available 
ergometer (e.g. cycle, treadmill, cross-trainer, stepper, rower, ski-erg, or arm crank). 
 
Data from patients attending the leisure facilities in the P4C programme, is collected using the 
ReferAll data collection system, which has been used in previous work examining exercise referral 
schemes (51-53). UK Active and GM Active have many years of experience working with the ReferAll 
system, which has been adapted to allow capture of data relating to both outcome and fidelity of 
the interventions in line with the Consensus on Exercise Reporting Template (CERT) (54).    
 
The knowledge from the project team and expert groups of the holistic needs of predicted patient 
cohorts led to areas for continued professional development (CPD) and education. This has included 
all GM Active fitness instructors involved in service delivery being trained in level 1 stepped-care 
model (46) communication SAGE and Thyme skills training workshop (55), bespoke nutritional 
screening (devised by cancer specialist dietitian members of the AHP Advisory Board), exercise 
prescription, prehabilitation overview and consideration of potential complex needs 
‘Prehab4Cancer’ participants may present with. There is on-going CPD training which includes 
facilitated reflective peer session with oncology specialist psychologist and programme lead to 
provide emotional support to staff delivering P4C intervention, as well as weekly education sessions 
covering topics such as severe and enduring mental health conditions and cognition. 
 
The P4C patient pathway 
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The starting point for the surgical P4C pathway is the Multi-disciplinary team decision to operate 
(See figure 3). In phase 1, all patients undergoing colorectal, lung and upper GI cancer surgery are 
offered ‘Prehab4Cancer’ without restriction. The patient is then referred through the GM Active 
‘Prehab4Cancer’ on-line referral form (https://www.gmactive.co.uk/prehab4cancer/). Here patient 
referral information including demographics, diagnosis, relevant past medical history and other 
specified details is provided by a named healthcare professional referrer to support on-going gym-
healthcare liaison and the creation of a ReferAll patient record. Upon receipt of the referral the P4C 
referral coordinator contacts the patient within 48 hours and arranges attendance at an initial 
assessment clinic within another 48 hours from telephone contact. This initial assessment clinic will 
be held at a local leisure facility within 5 miles or 30 minutes travel from the patient’s residential 
postcode. The assessment clinic is facilitated by one of the P4C Specialist Instructors, at one of the 
17 assessment clinics held weekly. The specialist instructors are trained in cardiac, pulmonary and 
cancer rehabilitation as well as qualifications on falls prevention, obesity & diabetes and 
musculoskeletal disorders to allow them to work with complex patients. 
At the initial assessment, a patient is assessed using P4C agreed clinical, physiological, functional and 
psychosocial metrics (Table 1). Details of their assessments are recorded on the ReferAll system. An 
exercise prescription is generated in line with the standardised intervention detailed above 
providing a combination of cardiovascular and resistance exercise with the aim for patients to attend 
a minimum of three gym sessions per week leading up to surgery and 2-3 sessions per week during 
neo-adjuvant chemotherapy . Following evaluation, patients are triaged into a targeted (less fit) or 
universal (fitter) pathway, which offer varying levels of supervision dependent upon patient fitness, 
nutritional needs, frailty, requirement for psychological support and ability to self-manage their 
exercise prescription independently in a potentially unfamiliar gym environment. Patients 
undergoing neo-adjuvant chemotherapy treatments as part of OG or lower GI cancer pathway are 
automatically entered into the targeted pathway, with the expectance that these patients will 
deteriorate in their endurance and physiologically during their oncological treatment. These neo-
adjuvant prehab pathways last for 2-3 months and continue up until surgery. 
 
In the targeted pathway for patients who require increased levels of support, patients attend for 
group sessions, with an attending exercise specialist or local instructor. The patient is monitored and 
HR data, RPE and Borg scales recorded during sessions.  The universal patients are provided with a 
detailed exercise programme to adhere to and educated on achieving their training zones at the gym 
with additional weekly regular specialist reviews for support. They are given details of the targeted 
group sessions, which they are invited to attend should they wish to and encouraged to undertake 
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other gym activities which appeal to them. On non-gym days all patients are encouraged to be active 
and aim to undertake 30 minutes of moderate physical activity, which can be spread throughout the 
day, in line with national physical activity advice (10).    
 
Once undertaking the P4C programme, patients are re-assessed using the same outcome metrics 
prior to surgery following their prehab phase, 4-6 weeks post-surgery when they are deemed 
physically able to resume engagement in exercise and again finally at the point of discharge from the 
service following 12 weeks of a recovery programme.  
 
In contrast to the prehab phase, which is deliberately prescriptive for those patients who have 
completed their treatment following surgery, the recovery phase aims to provide an exercise 
prescription which is more personalised to patient preference and physical activities which will be 
more likely to lead to long term behavioural change. P4C specialist instructors utilise the relationship 
they have developed with patients, as well as their local knowledge of available community 
resources to engage participants in physical activity they will be motivated to continue to do, whilst 
supporting their recovery from major surgery. Beyond the 12 weeks funded recovery phase, patients 
can be transitioned to other exercise referral schemes or subsidised, independent gym access 
dependent on the patient’s ongoing needs and the borough they live in.  
 
For patients who require further adjuvant therapies following surgery (OG and Lung adjuvant 
chemotherapy), their rehabilitation adopts a similar prescriptive nature to their prehab, which will 
be on-going through their post-op treatment. When this is completed, they will be offered transition 
to a recovery phase programme. 
 
‘Specialised’ P4C pathways aimed at those most high-risk patients experiencing sarcopenia and/ or 
moderate/severe frailty and subsequent higher risk of complications through surgery or other 
curative oncological treatment are now in development in GM. We are working with sports medicine 
and academic colleagues to explore the potential pathway, staffing groups (including AHPs working 
with specialist fitness instructors) and interventions that will help optimise this groups of patients.  
 
Evaluation of Prehab4Cancer  
 
Since it launched in April 2019, at the time of writing, over 600 patients from across the GM 
conurbation have participated in the P4C programme. Of colorectal patients (n=331), average age of 
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patients entering P4C is 67 (35-91), 60% are male with over 47% of patients in P4C over the age of 70 
and from all boroughs in GM. For lung (n=258) the average age of patients entering P4C is 69, with 
47% male and more than 57% of patients over the age of 70, with again representation from all over 
GM. Approximately 80% of people referred agree to attend their initial assessment and 95% of those 
attending this appointment engage in the programme, demonstrating acceptability for people 
diagnosed with cancer in GM. Initial participant feedback focus groups held at 6 months into the 
programme have generated consistently positive support for P4C.  
 
The high uptake rates from phase 1 cohorts will enable the second phase of patients undergoing 
major surgical procedures including hepato-pancreato-biliary surgery, head and neck and urology 
cancer diagnoses to commence in advance of the project’s planned delivery timeline along with lung 
cancer patients on non-surgical treatment pathways accessing the programme. 
 
Despite evidence for the efficacy of prehab and rehabilitation in controlled settings, robust 
evaluation of its ‘real world’ effectiveness is needed. By early 2021, P4C will have supported ~2,000 
patients to participate in freely accessible community-based prehab and recovery programmes 
across the GM region. Its successful implementation in GM presents a potential best practice ‘Whole 
Population’ model, adaptable for all appropriate cancer patients in the UK.  This work would, to our 
knowledge, represent the first large scale evaluation of a treatment pathway focused around cancer 
prehab and rehabilitation within a ‘real world’ context (i.e. within the context of usual day to day 
delivery of care) as opposed to within a controlled research context (i.e. a randomised controlled 
trial). Thus, we will generate evidence regarding the ‘real world’ effectiveness of Prehab4Cancer’s 
implementation that might support the sustainability and extension of the current programme, as 
well as the transferability and scalability of similar models of care delivery to be adopted by other 
local and combined authority areas in the UK. 
 
During P4C implementation, all patients referred into the service, and meeting the inclusion criteria, 
will have been offered the intervention. The majority of participants would be classed as older adults 
(over 65 years old), with many in their 70s, 80s and 90s. This will allow us to evaluate the role of 
prehabilitation in older patients who have traditionally been absent from cancer intervention trials 
(56-57). 
 
Throughout the programme, intervention fidelity and patient outcomes will be measured and 
digitally captured including survival rates, surgical complications, hospital readmissions, treatment 
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recovery, physiological and functional measures, and quality of life (QOL) patient reported outcomes 
(PROMs). This dataset, in combination with historic ‘legacy’ datasets representing usual care models, 
will enable the evaluation to take place and allow a pragmatic evaluation of Prehab4Cancer. 
 
Conclusion 
The introduction of ERAS+ in 2015 as a new pathway in Greater Manchester (GM) including a 
prehabilitation advice and support package, in-hospital best care surgical model, and post-hospital 
recovery supporting patients, has already led to rapid improvements in post-surgical complications 
and costs (unpublished GM ERAS+ data).  
 
With the addition of P4C, GM Cancer is the first regional system in the UK to introduce delivery of 
system-wide, large scale physical activity supported multi-modal prehabilitation and recovery 
interventions as a standard of care for cancer patients. P4C to date has focused on robust co-design, 
development, and implementation of an effective service model with attention paid to stakeholder 
engagement. This has led to receipt of high numbers of referrals from across GM for the all the 
cancer groups involved. Prehab in older and more frail patients will be reviewed in the evaluation of 
the current P4C model, which will help in the design of the specialised prehabilitation models for 
patients in GM. 
 
The successful implementation of the P4C pathway in GM presents a best practice model that might 
be adopted by other local and combined authority areas nationally. However, robust evaluation is 
needed to evidence its effectiveness, ‘value for money’ and to help maximise its impact to influence 
the case for national adoption of prehabilitation service delivery. 
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Table 1: P4C outcome metrics 
Type: Outcome Measure: 
Physiological measures:  
Functional dynamic test 6 Minute Walk Test (6MWT) 
 
Incremental Shuttle Walk Test (ISWT) 
Weight  To be measured in kilograms. 
Height To be measured in metres. 
Heart Rate/BP Resting heart rate/BP. Plus recording heart rate range during sessions. 
Oxygen saturation Levels Recorded at rest and throughout the 6MWT/ISWT 
Resistance Rep max percentage programming. 
 
Heaviest weight you can lift for 10 consecutive exercise repetitions. 
Quad, Core, Shoulder. 
 
Grip Strength Hand Grip Strength (dynamometer) measured in kg 
Bespoke nutritional screening assessment takes into account Body Mass Index (BMI), weight trend (loss 
or gain), changes in ability to swallow solid food (IDDSI food and drink descriptors) and hand grip strength.  
Patient Reported Outcome Measures (PROMs):  
General Health and Wellbeing  
(Quality of Life - QOL) 
EQ-5D-5L 
 
Descriptive system of health-related quality of life states consisting of 
five dimensions (mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression) each of which can take one of five responses. The 
responses record five levels of severity (no problems/slight 
problems/moderate problems/severe problems/extreme problems) 
within a particular EQ-5D dimension. 
Physical Activity 
International Physical Activity Questionnaire-Short Form (IPAQ – 
SF) 
 
The IPAQ assesses physical activity across a comprehensive set of 
domains including: 
a) Leisure time physical activity, 
b) Domestic and gardening activities, 
c) Work-related physical activity, 
d) Transport-related physical activity. 
 
N.B. Developed and tested for use in adults (age range 15 to 69 years), 
not validated in older adults. 
 
https://sites.google.com/site/theipaq/background 
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Cancer-specific QOL EORTC QLQ-C30 (version 3) 
 
This is a QOL questionnaire targeted to the management of chronic 
illness. It is included in the NHS England recommended Living with and 
Beyond Cancer/Personalised Care QOL metrics. It asks more extensive 
QOL questions which go beyond the EQ-5D. 
 
Frailty (Activities of Daily Living) Rockwood Clinical Frailty Scale 
Disability World Health Organisation Disability Assessment Schedule 2.0 
(WHODAS 2.0) 
 
This self-administered questionnaire asks about difficulties related to 
health conditions that impact on someone’s ability to do their daily 
activities. 
 
Efficacy Self-Efficacy for Exercise Scale 
 
This supports action planning to identify barriers to engagement as the 
patient accesses the programme whilst also focusing on confidence 
levels and general self-efficacy of the patient to engage in exercise. 
Patient Reported Experience Measure(s)  (PREMs): 
Participant Experience NHS Family and Friends Test 
 
Bespoke ‘Prehab4Cancer’ participant experience survey  
 
 
Table1: examples of cardiovascular and resistance training dose prescription used in P4C 
programme 
 
Table 2. Examples of cardiovascular and resistance training exercise dose prescription. Note: Most patients received 3 
weeks and progression is built around this length of time between diagnosis and surgery. Exercise past this time continues 
to progress or maintains at week 3 prescription.  
 Resistance training Cardiovascular training 
 Week 1 Week 2 Week 3  Week 1 Week 2 Week 3 
How potent? 
 
Intensity of 
effort 
 
 
nRM 
RP-E/D 
 
 
sdRM 
RP-E/D 
 
 
~MF 
RP-E/D 
How potent? 
 
Intensity of 
effort 
 
12-13 RPE 
Borg Scale* 
 
14-17 RPE 
Borg Scale* 
 
18+ RPE 
Borg Scale* 
How much? 
 
Repetitions 
Load 
Sets 
(Rest-sets) 
 
 
15-18 reps 
~50-60%1RM 
2 
2-4 mins 
 
 
8-12 reps 
n/a 
2 
2-4 mins 
 
 
8-12 reps 
n/a 
1 
n/a 
How much? 
 
Duration 
Speed/Power 
Bouts 
 
 
30 mins     
n/a 
1 
 
20 mins     
n/a 
1 
(RE-HIIT*) 
10-20 secs  
n/a              
2 
How often? 
 
Frequency 
 
3x/week 
 
3x/week 
 
3x/week 
How often? 
 
Frequency 
 
3x/week 
 
3x/week 
 
3x/week 
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Decision Rules 
Starting level 
Progression 
 
~50-60%1RM (Brzycki formula*) 
From week 2; + <10% load if >12 reps before 
set end point achieved 
Decision 
Rules 
Starting level 
Progression 
 
Determined by initial fitness (i.e. RPE) 
Based upon changing fitness (i.e. RPE) 
Resistance training intensity of effort based upon set endpoints and rating of perceived effort (48,52); nRM = not repetition 
maximum; sdRM = self-determined repetition maximum; MF = momentary failure; 1RM = one repetition maximum; RP – 
E/D = rating of perceived effort (effort/discomfort); RE-HIIT = reduced exertion – high intensity interval training (see 
Metcalfe et al., 2012) 
 
 
 
 
Figure 2: GM Cancer surgery pathway incorporating ERAS+ and P4C 
 
Figure 3: P4C Governance Structure 
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